Using peripheral blood indicators and T cells subsets to evaluate the efficacy of immunotherapy for advanced and recurrent cervical cancer.

By Bai J, Cui XL, Bo SJ, Sun L.

journal article · Hum Vaccin Immunother (2026)

This headline was gathered automatically from a public feed. I AM GRACE does not host the full article — you will be taken to the original publisher.